Teva Pharmaceuticals to pay $4.2 billion opioid settlement; New York to get $523 million - CBS New York
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
How the Opioid Litigation Against Drug Companies Could Play Out. | Barron's
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Teva to pay $85m to Oklahoma over opioid case | Financial Times
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva to settle opioid claims, but with no admission of wrongdoing
Teva Pharm Expects to Start Paying U.S. Opioid Settlement in 2023: CEO
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Teva's generic naloxone nasal spray approved
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
New York could get $524M under opioid settlements with Teva - ABC News
Teva finalizes terms of US opioid settlement worth $4.25 billion | The Times of Israel
Teva fueled opioid addiction in New York, jury finds | amNewYork
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Attorney General Josh Stein Finalizes $6.6 Billion in Agreements with Opioid Makers Teva and Allergan - NCDOJ
New York jury holds drug firm Teva liable in opioid crisis
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Opioid Manufacturers Teva and Allergan Face Insurance Fraud Charges : Risk & Insurance
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Rhode Island's Opioid Trial Against Teva Begins Wednesday, CVN Webcasting Gavel-to-Gavel
